382 related articles for article (PubMed ID: 12020864)
1. Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms.
Tierno A; Fiore P; Gannon RL
Brain Res; 2002 May; 937(1-2):66-73. PubMed ID: 12020864
[TBL] [Abstract][Full Text] [Related]
2. Opioid induced non-photic phase shifts of hamster circadian activity rhythms.
Byku M; Gannon RL
Brain Res; 2000 Aug; 873(2):189-96. PubMed ID: 10930543
[TBL] [Abstract][Full Text] [Related]
3. SNC 80, a delta-opioid agonist, elicits phase advances in hamster circadian activity rhythms.
Byku M; Gannon RL
Neuroreport; 2000 May; 11(7):1449-52. PubMed ID: 10841355
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.
Gannon RL
Neuroscience; 2003; 119(2):567-76. PubMed ID: 12770569
[TBL] [Abstract][Full Text] [Related]
5. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
[TBL] [Abstract][Full Text] [Related]
7. Effects of systemically applied nAChRα7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythms.
Gannon RL; Garcia DA; Millan MJ
Eur Neuropsychopharmacol; 2014 Jun; 24(6):964-73. PubMed ID: 24388152
[TBL] [Abstract][Full Text] [Related]
8. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors.
Gannon RL; Millan MJ
Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878
[TBL] [Abstract][Full Text] [Related]
9. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
Pakarinen ED; Woods JH; Moerschbaecher JM
J Pharmacol Exp Ther; 1995 Feb; 272(2):552-9. PubMed ID: 7853168
[TBL] [Abstract][Full Text] [Related]
10. Effects of the 5HT1A agonist/antagonist BMY 7378 on light-induced phase advances in hamster circadian activity rhythms during aging.
Byku M; Gannon RL
J Biol Rhythms; 2000 Aug; 15(4):300-5. PubMed ID: 10942261
[TBL] [Abstract][Full Text] [Related]
11. The opioid fentanyl affects light input, electrical activity and Per gene expression in the hamster suprachiasmatic nuclei.
Vansteensel MJ; Magnone MC; van Oosterhout F; Baeriswyl S; Albrecht U; Albus H; Dahan A; Meijer JH
Eur J Neurosci; 2005 Jun; 21(11):2958-66. PubMed ID: 15978007
[TBL] [Abstract][Full Text] [Related]
12. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
Lall GS; Biello SM
Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
[TBL] [Abstract][Full Text] [Related]
14. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
15. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
Matsuzawa S; Suzuki T; Misawa M; Nagase H
Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
[TBL] [Abstract][Full Text] [Related]
16. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
Gannon RL; Millan MJ
Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
[TBL] [Abstract][Full Text] [Related]
17. The corticotropin-releasing factor (CRF)(1) receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Brain Res; 2006 Apr; 1083(1):96-102. PubMed ID: 16551464
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of constant light on circadian clock resetting by photic and nonphotic stimuli in Syrian hamsters.
Landry GJ; Mistlberger RE
Brain Res; 2005 Oct; 1059(1):52-8. PubMed ID: 16169532
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
20. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
